Clinical trial
A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
NCT01400893 is registered in ClinicalTrials.gov with SeaStar Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Randomized, Controlled, Pivotal Study To Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) In Patients With Acute Kidney Injury (AKI)
- Lead sponsor
- SeaStar Medical
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- August 31, 2011
- Completion date
- September 30, 2013
- Enrollment
- 134 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.